An evaluation of increasing doses of ranitidine for treatment of heartburn

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 4, 1999, Pages 475-481

  Pappa, K A ^a   Buaron, K ^a   Payne, J E ^a   Sirgo, M A ^a   Giefer, E E ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM MAGNESIUM HYDROXIDE; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTI-ULCER AGENTS; DRUGS, NON-PRESCRIPTION; FEMALE; HEARTBURN; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RANITIDINE; SELF ADMINISTRATION; TREATMENT OUTCOME;

EID: 0032918387     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00506.x     Document Type: Article

References (14)

1. Saunders JHB, Oliver RJ, Higson DL. Dyspepsia incidences of non-ulcer disease in a controlled trial of ranitidine in general practice. Br Med J 986; 292: 665-8.
2. Guslandi M, Nannini D, Passaretti S, Ballarin E. A comparison between sucralfate and ranitidine in the management of non-ulcer dyspepsia. Clin Ter 1986; 119: 289-92.
3. Sontag S, Robinson M, McCallum RW, Barwick KW, Nardi R. Ranitidine therapy for gastroesophageal reflux disease: Results of a large double-blind trial. Arch Intern Med 1987; 147: 1485-91.
4. Nelis GF. Ranitidine in the management of gastroesophageal reflux disease. Neth J Med 1985; 28: 197-200.
5. Nebel OT, Castell DO, Lower Oesophageal sphincter pressure changes after food ingestion. Gastroenterology 1972; 63: 778-83.
6. Dent WJ, Dodds WJ, Friedman RH, et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980; 65: 256-67.
7. Dodds WJ, Dent WJ, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux oesophagitis. N Engl J Med 1982; 307: 1547-52.
8. Lanza FL, Smith V, Page-Castell JA, Castell DO. Effectiveness of foaming antacid in relieving induced heartburn. South Med J 1986; 79: 327-30.
9. Richter JE. Heartburn, dysphagia, odynophagia, and other oesophageal symptoms. Gastrointestinal Disease. Fifth Edn. Philadelphia: W.B. Saunder Co., 1993, 331-40.
10. Decktor DL., Robinson M, Maton PN, Lanza FL, Gottlieb S. Effects of aluminum/magnesium hydroxide and calcium carbonate on oesophageal and gastric pH in subjects with heartburn. Am J Ther 1995; 2: 546-52.
11. Decktor DL, Robinson M, Gottlieb S. Comparative effects of liquid antacids on Oesophageal and gastric pH in patients with heartburn. Am J Ther 1995; 2: 481-6.
12. Wyeth JW, Pounder RE, Sercombe JC, Snell CC. The effects of low-doses of ranitidine on intragastric acidity in healthy men. Aliment Pharmacol Ther 1998; 12: 255-61.
13. Sirgo MA, Schactel BP. Development of gastrointestinal drugs for over-the-counter indications. Gastrointestinal Pharmacology & Therapy, 1st Edn. Philadelphia: Lippincott-Raven, 1996; 723-41.
14. Merck and Co. Public Presentation of Pepcid to Joint Gastrointestinal and Non-Prescription Drugs Advisory Committee, July 27-29 1994, Washington DC.